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Post-treatment cancer care is often fragmented and of suboptimal quality. We explored factors that 
may affect cancer survivors’ post-treatment care coordination, including oncologists’ use of 
electronic technologies such as e-mail and integrated electronic health records (EHRs) to 
communicate with primary care physicians (PCPs). We used data from a survey (357 respondents; 
participation rate 52.9%) conducted in 2012–2013 among medical oncologists caring for patients 
in a large U.S. study of cancer care delivery and outcomes. Oncologists reported their frequency 
and mode of communication with PCPs, and role in providing post-treatment care. Seventy-five 
percent said that they directly communicated with PCPs about post-treatment status and care 
recommendations for all/most patients. Among those directly communicating with PCPs, 70% 
always/usually used written correspondence, while 36% always/usually used integrated EHRs; 
telephone and e-mail were less used. Eighty percent reported co-managing with PCPs at least one 
post-treatment general medical care need. In multivariate-adjusted analyses, neither 
communication mode nor intensity were associated with co-managing survivors’ care. 
Oncologists’ reliance on written correspondence to communicate with PCPs may be a barrier to 
care coordination. We discuss new research directions for enhancing communication and care 
coordination between oncologists and PCPs, and to better meet the needs of cancer survivors post-
treatment.
Keywords
healthcare provider communication; care coordination; cancer care delivery; cancer survivorship; 
primary care physician
INTRODUCTION
Post-treatment care of cancer survivors is complex and may involve monitoring for 
recurrence, managing long-term or late effects of cancer treatment and co-morbid 
conditions, and providing overall health promotion and preventive care. Survivors receive 
care from a variety of providers, including cancer specialists, primary care physicians 
(PCPs), nurses, mental health care professionals, and other clinicians (Institute of Medicine, 
2006).
Expert groups have called for shared models of post-treatment cancer care, in which PCPs 
and other non-oncologist providers collaborate with oncologists to deliver survivors’ health 
care (Institute of Medicine, 2006). However, poor communication and lack of coordination 
by those involved in survivors’ care can contribute to fragmented care delivery and adverse 
patient outcomes (Criscitelli 2013; Dawson 2011; Dunn and Markoff, 2009; Earle and 
Neville, 2004; Epstein 1995; Haldis and Blankenship, 2002; Shannon 2012). Reasons for 
poor communication and collaboration are varied and include lack of time, interest, or 
knowledge; lack of reimbursement for time spent communicating with other providers; 
unclear treatment goals; inadequate discharge planning; lack of clarity about the respective 
roles of PCPs and specialists; differences in values; and preferences of the patient and family 
(Dworkin et al., 1998; Earle and Neville, 2004; Shannon 2012; Sutcliffe et al., 2004; Wood 
and McWilliam, 1996).
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The issue of fragmented survivorship care delivery is important because the number of 
cancer survivors and constraints on the cancer care system continue to grow. An estimated 
14.5 million cancer survivors are living in the United States today, and the number is 
expected to increase to almost 19 million by 2024 (American Cancer Society, 2014; 
DeSantis et al., 2014). At the same time, workforce shortages among the providers who care 
for cancer survivors are growing, training programs are not expanding rapidly enough to 
accommodate demand, and the costs of cancer care are escalating (Institute of Medicine, 
2013; Yang et al., 2014). The convergence of these trends requires new approaches to 
coordinated, evidence-based care.
Relatively few studies have examined effective approaches to improving provider 
communication and enhancing coordination in cancer care. One study of PCPs’ and 
specialists’ perceptions of communications about referrals and consultations showed that 
three practice characteristics were related to better reported communication: adequate visit 
time with patients, receipt of quality reports on patients’ chronic conditions, and nurse 
support for monitoring patients with chronic conditions (O’Malley and Reschovsky, 2011). 
Two Canadian studies addressed collaboration between family physicians and oncologists in 
cancer care. Dworkin et al. (1998) found that family physicians wish to be more involved in 
all stages of cancer care but desire face-to-face or telephone communications to negotiate 
roles and discuss patients’ care. Wood and McWilliam (1996) documented that oncologists 
considered collaboration to be desirable but were hampered by their own variable interest, 
poor communication with family physicians, and patients’ preferences for follow-up care. A 
U.S. study showed that PCPs are more engaged in sharing or co-managing cancer survivors’ 
care than are oncologists (Klabunde et al., 2013).
The goal of the present study is to explore factors that may affect cancer survivors’ post-
treatment communication and care coordination. We used data from the Cancer Care 
Outcomes Research and Surveillance (CanCORS) consortium, a U.S. initiative to study the 
care and outcomes experienced by approximately 10,000 patients diagnosed with lung or 
colorectal cancer between 2003–2005 (Ayanian et al., 2004), to (1) examine oncologists’ 
methods of communicating with PCPs about cancer patients post-treatment, (2) characterize 
oncologists’ involvement in post-treatment care, and (3) assess factors—including use of 
electronic communication technologies such as e-mail and integrated electronic health 
records (EHRs)—that may be associated with oncologists’ co-management with PCPs of 
survivors’ post-treatment care.
METHODS
Study Design
The study setting is the CanCORS initiative, which collected data from cancer patients, their 
caregivers, and their physicians from 2003–2013. CanCORS participating sites included 
eight counties in Northern California, Los Angeles county, the states of Iowa and Alabama, 
22 counties in central/eastern North Carolina, five integrated delivery systems, and 15 
Veterans Affairs (VA) medical centers. Two surveys of physicians were conducted. The first 
(CanCORS I) was fielded in 2005–2006 among 6871 physicians named by CanCORS 
patients as filling one or more key roles in their care (Keating et al., 2008). The second 
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(CanCORS II) was conducted in 2012–2013 among 679 medical oncologists who had 
participated in the first survey or were identified as care providers in medical record 
abstractions or in a separate survey of CanCORS patients with advanced cancer that was 
fielded in 2010–2011 (Kehl et al., 2015; Cancer Care Outcomes Research and Surveillance 
Consortium, 2016). The survey protocol was approved by the Institutional Review Boards of 
all participating sites. Our study uses data from the CanCORS II medical oncologist survey.
Medical oncologists were mailed a self-administered questionnaire during June–August 
2012. They also could participate in the survey through a secure website. A $50 incentive 
check was included in the questionnaire mailing. Nonrespondents were sent up to two 
additional mailings of the questionnaire and received up to four telephone contacts to verify 
receipt of the mailing and encourage participation in the survey. Attempts to follow-up 
nonrespondents concluded in May 2013. The survey’s participation rate among oncologists 
whose contact information could be verified was 52.9%. Comparison of responding and 
nonresponding oncologists on selected characteristics (i.e., sex, U.S. or Canadian medical 
school graduation, years since medical school graduation) revealed no statistically 
significant differences.
Survey Instrument
The CanCORS II questionnaire included a section addressing oncologists’ opinions and 
practices concerning delivery and coordination of follow-up care for patients completing 
active treatment. Information about oncologists’ personal and practice demographics also 
was collected; these items were adapted from the CanCORS I physician survey. The full 
instrument underwent two rounds of cognitive testing with nine practicing medical 
oncologists. Cognitive testing results were used to refine the instrument and reduce its 
length. The final instrument is available at https://www.cancors.org/public/servlets/open/
home/home.cmd?itab=2.
To explore oncologists’ perspectives and involvement regarding cancer patients’ post-
treatment care, we asked respondents about the number of patients whose PCPs they had 
directly communicated with about the patient’s status and post-treatment recommendations 
(“all patients,” “most patients,” “some patients,” and “no patients”). Respondents who 
indicated that they directly communicated with PCPs for at least some of their patients were 
asked about the modes by which they communicated clinical information to PCPs: “phone 
conversation,” “written correspondence,” “e-mail,” and “alerts or correspondence through 
integrated EHRs.” For each communication mode, respondents indicated whether they 
“never,” “sometimes,” “usually,” or “always” used it.
We also asked respondents about their role versus that of the PCP in managing patients’ 
post-treatment general medical and cancer-related care needs. These care needs included: 1) 
routine screening for other cancers, 2) newly diagnosed hypertension requiring treatment, 3) 
new 15-pound weight gain in a previously overweight patient, 4) development of depression, 
5) smoking a half-pack or more of cigarettes per day, 6) new sexual dysfunction, 7) regular 
surveillance for lung or colon cancer, 8) new iron deficiency anemia in a colorectal cancer 
survivor, 9) new diarrhea in a rectal cancer survivor who does not have an ostomy, 10) new 
cough of four weeks’ duration in a lung cancer survivor, and 11) progressive shortness of 
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breath in a lung cancer survivor. The scenarios were developed to assess the extent to which 
oncologists assumed the general medical care needs of cancer survivors. Clinical policy 
highlights the broad range of ongoing needs, both cancer and non-cancer related, that cancer 
survivors face. We chose a diverse range of scenarios—cancer screening, surveillance, 
healthy behaviors, symptom management, and urgent care—to better understand how 
oncologists’ involvement in clinical management may vary across different clinical domains. 
For each care need, respondents were asked to indicate whether they would take 
responsibility for managing it, the PCP or another physician would take responsibility, they 
would share responsibility with the PCP or another physician (i.e., co-manage), or handle it 
in some other way. We classified scenarios 1–6 as fulfilling patients’ general medical care 
and scenarios 7–11 as fulfilling patients’ cancer-related care needs.
Measures
We created two composite measures of oncologists’ methods of communicating with PCPs. 
The first (measure 1) was intended to assess whether the mode of communication, 
specifically use of electronic technologies such as integrated EHRs and e-mail, is associated 
with co-managing post-treatment care with PCPs. The second (measure 2) was intended to 
examine whether intensity of communication is associated with co-managing care. For 
measure 1, we assigned oncologists to one of four categories: those indicating that they more 
often use electronic technologies (integrated EHR and/or e-mail), those responding that they 
more often use traditional technologies (written correspondence and/or telephone), those 
with no dominant pattern of use, and those who do not directly communicate with patients’ 
PCPs using these modes. For measure 2, we assigned oncologists to one of three categories: 
those indicating that they always/usually use more than one of these modes to communicate 
with PCPs, those responding that they always/usually use one mode, and those always/
usually using none of these modes.
Oncologists responding that they “share responsibility with the PCP or another physician” 
for one or more of the survey’s six post-treatment general medical care scenarios were 
classified as co-managing care. To characterize the extent to which oncologists co-manage 
patients’ general medical care needs with PCPs, we summed the number of roles that the 
respondent reported co-managing; this measure ranged from 0 (i.e., co-manages no roles) to 
6 (i.e., co-manages all roles).
Data Analysis
We used descriptive statistics to summarize oncologists’ demographic and practice 
characteristics; their beliefs about follow-up care for cancer patients post-treatment; their 
practice style, including communication frequency, mode, and intensity; and their reported 
involvement in managing patients’ post-treatment care needs. We used ordinal logistic 
regression modeling to examine factors associated with oncologists’ engagement in co-
managing patients’ general medical care needs with PCPs. To assess whether mode and/or 
intensity of communication were associated with co-managing care, we estimated two 
models. The first included the mode of communication composite variable (measure 1), and 
the second included the intensity of communication composite variable (measure 2). The 
dependent variable in both models was the number of general medical care needs that were 
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co-managed. Physician demographic, practice setting, beliefs, and practice style variables 
were included as independent variables in both models. All analyses were conducted with 
SUDAAN software version 11.0.1 (RTI International; Research Triangle Park, NC, USA) 
and a survey dataset in which multiple imputation was used to impute missing data for most 
survey items (He and Zaslavsky, 2007; Little and Rubin, 2002).
RESULTS
Characteristics, beliefs, and practices of respondents
The majority of oncologists were male, non-Hispanic white, U.S. or Canadian medical 
school graduates, and board-certified (Table 1). One-quarter were less than 20 years from 
medical school graduation, while almost half had graduated from medical school 30 years 
ago or longer, consistent with the fact that most of these fellowship-trained physicians in our 
cohort had originally cared for patients who were diagnosed with cancer in 2003–2005. 
Most oncologists were in office-based practices that did not include a PCP and that used a 
full EHR system. Sixty-one percent were in practices that had ten or fewer physicians. 
About half saw from five to 20 newly diagnosed lung or colorectal cancer patients in a 
typical month. Less than half were engaged in teaching medical students or residents. 
Relatively few (<25%) expressed the belief that early-stage lung or colorectal cancer 
survivors should continue regular follow-up visits to the oncologist indefinitely.
Communication with PCPs
About half of oncologists reported that they directly communicated with their patients’ PCPs 
about post-treatment status and recommendations for all patients completing adjuvant 
chemotherapy within the prior three months (Table 1). One-quarter indicated that they 
directly communicated with the PCP for most patients, while 13 percent reported that they 
did so for some patients. Twelve percent of oncologists said that they did not directly 
communicate with PCPs about patients’ post-treatment status and recommendations.
Oncologists who directly communicated with PCPs about patients post-treatment reported 
on the modes of communication they used (Figure 1). Overall, written communication was 
the most frequently identified mode (86.3%), followed by telephone (76.8%), integrated 
EHR (57.9%), and e-mail (43.9%). Of the communication modes that oncologists reported 
always or usually using, written correspondence was mentioned by more than two-thirds, 
and integrated EHRs by about one-third. Only 15% identified e-mail and <10% reported 
telephone as communication modes that they always/usually used. Sixty-eight percent 
reported sometimes using telephone. More than 50% indicated that they never used e-mail, 
and 42% said that they never used integrated EHRs.
Examination of communication patterns across the four modes showed that the majority of 
oncologists (59%) always/usually used one mode of communication, while 24 percent 
always/usually used more than one mode to communicate with PCPs (Table 1). Forty-seven 
percent more often used the traditional modes of written correspondence or telephone, while 
21 percent more often used the electronic technologies of integrated EHRs or e-mail. 
Twenty-one percent reported no dominant mode of communicating with PCPs. The response 
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patterns of 17% of oncologists indicated that they did not routinely communicate with PCPs 
with these modes.
Involvement in managing patients’ post-treatment care needs
The majority of oncologists reported that they personally managed their patients’ post-
treatment cancer-related care needs, including regular surveillance for the patient’s lung or 
colorectal cancer (82%), and addressing new iron deficiency anemia in a colorectal cancer 
survivor (80%), new cough of four weeks’ duration (67%) or progressive shortness of breath 
(64%) in a lung cancer survivor, and new diarrhea in a rectal cancer survivor (57%) (Table 
2). Less than a third indicated that they co-managed any of these cancer-related care needs 
with PCPs.
In contrast, one-quarter or fewer of oncologists reported leading the management of 
patient’s post-treatment general medical care needs (Table 3). Co-managing with the PCP 
was a dominant pattern for active smoking (58%) and development of depression (51%), 
while the PCP or other physician as lead was a dominant pattern for newly diagnosed 
hypertension (83%), new 15-pound weight gain (63%), and routine cancer screening (45%). 
For managing new sexual dysfunction, 51% of oncologists indicated that the PCP or other 
physician was responsible, while 42% co-managed this care with the PCP.
The mean number of patient’s six post-treatment general medical care needs that oncologists 
reported co-managing with PCPs was 2.2 (95% CI: 2.0–2.4). Eighty percent (95% CI: 75.4–
84.0) of oncologists indicated that they co-managed at least one general medical care need 
(data not shown).
Factors associated with co-managing patients’ post-treatment care needs with PCPs
Results from ordinal logistic regression modeling of factors associated with co-managing a 
greater number of patients’ post-treatment general medical care needs are shown in Table 3. 
Oncologists located in northern California, Los Angeles county, North Carolina, or 
practicing in VA medical centers were more likely than Iowa oncologists to co-manage care 
needs with PCPs. Oncologists’ mode of communicating patients’ post-treatment clinical 
information with PCPs was not associated with greater co-management. In a separate model, 
intensity of communicating with PCPs (i.e., always/usually using more than one 
communication mode) also was not associated with co-managing care (data not shown).
DISCUSSION
Using information obtained from medical oncologists practicing in diverse locations and 
settings in the United States, we explored factors that may affect post-treatment 
communication and care coordination between medical oncologists and PCPs. We found that 
not all oncologists directly communicate with patients’ PCPs about post-treatment status and 
recommendations. For those who do, written correspondence is a preferred communication 
mode, despite growing emphasis on and availability of electronic communication 
technologies such as e-mail and integrated EHRs. We also found that more than 80 percent 
of oncologists co-manage post-treatment general medical care with the patient’s PCP, but 
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their engagement in co-management is limited to one or two care needs. We further 
examined whether oncologists’ use of e-mail or integrated EHRs was related to greater 
engagement in co-management with PCPs, but this potential association was not 
demonstrated in our multivariable modeling.
Given the heightened attention that provider communication and care coordination in cancer 
survivorship care has received in recent years (Aiello Bowles et al., 2008; Grunfeld and 
Earle, 2010; Institute of Medicine, 2006), our finding that 13% of oncologists reported 
directly communicating with patients’ PCPs for only some patients, and 12% did not 
directly communicate with the PCP for any of their patients is both notable and concerning. 
Prior studies have documented oncologists’ lack of confidence in PCPs’ ability to manage 
cancer survivors’ post-treatment care (Potosky et al., 2011), as well as the expectations of 
many survivors that their cancer specialist—and not their PCP—should be their main 
provider for follow-up care (Chubak et al., 2014). These factors, along with limited or 
inadequate office systems to assist the oncologist in locating and communicating with PCPs, 
may contribute to a lack of communication on the part of some oncologists. As few studies 
have examined provider communication strategies and barriers in survivorship care, future 
research to explore reasons that oncologists may not directly communicate with PCPs is 
warranted.
We also found that, among oncologists who do directly communicate with patients’ PCPs 
post-treatment, most rely on a single mode of communication, and written correspondence is 
a preferred mode. Notably, less than one-quarter of oncologists reported using EHRs or 
email to communicate with PCPs, despite the fact that 70% of the oncologists in our study 
were in practices with full EHRs. Our results may reflect a lack of integration of EHR 
systems across practice settings—not unusual for small practices in the U.S.— which would 
be a major barrier for oncologists who need to communicate with PCPs outside of their 
practice and/or who do not share an integrated EHR system (Fasola et al., 2014; Sada et al., 
2011). Two-thirds of the oncologists in our study were in practices that did not include 
PCPs, suggesting that lack of interoperability of EHR systems may be a factor impeding 
communication using electronic technologies. Moreover, there is growing recognition that 
EHRs have created greatly expanded information capture on patients and that it can be time-
consuming and difficult for clinicians to extract useful information from them (Clynch and 
Kellett, 2015; Woods et al., 2008). The capabilities and effectiveness of EHR systems as an 
oncologist-PCP communication mode require further investigation. Participation of both 
oncology specialty and primary care practices in regional health information exchange 
programs would be one way to connect EHRs and practices (Haggstrom and Doebbeling, 
2011). Future research is also needed to assess oncologists’ and PCPs’ preferences for and 
perceived barriers to communication modes, such as face-to-face, written correspondence, 
telephone, email, integrated EHRs, and others.
Consistent with our finding that the extent and mode of oncologists’ communication with 
PCPs is variable and often limited, we documented that oncologists’ engagement in co-
managing patients’ post-treatment care needs with PCPs is modest. Prior studies have 
reported similar results (Klabunde et al., 2013; Rose et al., 2012). In our study, co-
management was more common for general medical care than cancer-related care needs and 
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most often reported for addressing active smoking and development of depression, with 
slightly over one-half of oncologists indicating that they co-manage these needs. Contrary to 
our expectation, use of electronic communication technologies such as e-mail and integrated 
EHRs was not associated with greater engagement by oncologists in co-managing survivors’ 
care. Although shared-care models have been proposed as an optimal strategy for addressing 
cancer survivors’ many needs (Cohen 2009; McCabe et al., 2013; Sada et al., 2011), they 
require further development and evaluation. With the cancer survivor population in the U.S. 
continuing to grow at the same time that oncologist workforce shortages are becoming more 
acute, identifying efficient and effective ways to promote co-managed or shared survivorship 
care among oncologists, PCPs, and other clinicians is a critical area for new research. One 
promising tool that merits further investigation is the use of “care coordination agreements”, 
which delineate in writing the specific responsibilities of two or more parties for ensuring 
coordinated care (Carrier et al, 2012).
In our multivariable modeling, oncologists’ practice setting (i.e., geographic location, VA 
medical center setting) was the only characteristic associated with co-management. This 
finding parallels studies of co-management during hospitalization that have shown 
variability in use across patients and hospitals (de Vries et al., 2014). Our results may 
indicate that professional community norms, rather than communication or technology 
modes, have the greatest influence on levels of co-management, and suggest the need for 
further research that incorporates more comprehensive patient- and practice-level data to 
assess factors associated with co-management.
Our study has several strengths, including its sample of oncologists from diverse geographic 
regions and practice settings throughout the U.S., most of whom were engaged in caring for 
cancer patients in the CanCORS initiative for a decade or longer. There are also several 
limitations. Although the study sample was a census of all the medical oncologists in the 
targeted sites, the relatively small sample size (n=357) may have contributed to a lack of 
statistical power to detect associations between oncologists’ personal and practice 
characteristics, communication mode and intensity, and engagement in co-managing care. 
We surveyed oncologists only; future studies should examine approaches to communication 
and care coordination for cancer survivors that explore the perspectives of PCPs and other 
relevant clinicians. Our survey addressed four communication modes (written 
correspondence, telephone, integrated EHR, and e-mail), but did not capture others that may 
be important and useful to oncologists in the future. For example, social media networks 
may be a new way for providers to interact efficiently with each other, and with patients, but 
more interactively (Kolowitz et al., 2014). The structured survey format did not enable us to 
assess in depth what oncologists mean when they report that they co-manage or share 
responsibility for survivorship care with PCPs or other clinicians. Finally, because many of 
the physicians in our cohort were practicing in 2003–2005, younger physicians—who may 
have different communication practices—were underrepresented.
The Institute of Medicine has referred to the cancer care system in the U. S. as being “in 
crisis’, and identified coordinated, comprehensive, patient-centered care as a critical need 
(Institute of Medicine, 2013). Other influential groups have called for creative strategies for 
leveraging the oncology workforce to meet this need, including collaborating and 
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coordinating with PCPs (American Society of Clinical Oncology, 2014). The results of our 
study, which summarizes direct reports from medical oncologists in the U.S. and focuses on 
their post-treatment communication and care coordination with PCPs, point to several 
challenges in achieving these goals. Future efforts to assess and facilitate communication 
and care coordination between oncologists and PCPs could capitalize on practice redesign 
efforts, such as patient-centered medical homes and implementation of EHRs and other 
health information technology systems, that are underway in oncology and in primary care. 
There also is need for assessment of evolving clinician communication devices and 
technologies, such as tablets and smartphones (McElroy et al., 2013), which are largely 
unstudied but may play a growing role in enhancing communication and care coordination 
among providers. As advances in cancer detection and therapeutics continue to expand the 
cancer survivor population, identification and implementation of optimal communication 
and care coordination approaches will be imperative to better meet survivors’ post-treatment 
care needs and ultimately improve outcomes.
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Figure 1. 
Oncologists’ methods of communicating clinical information with PCPs about patients 
completing adjuvant chemotherapy
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Table 1
Characteristics, beliefs, and practices of participating oncologists (n=357)
N (%)
Physician characteristics
  Gender: (Male) 266 (74.7)
  Years since graduation from medical school:
    <20 85 (24.4)
    20–29 107 (30.6)
    ≥30 157 (45.0)
  Race/ethnicity:
    Non-Hispanic White 238 (66.7)
    Non-Hispanic Asian 83 (23.2)
    Other 36 (10.1)
  Board certified: (Yes) 345 (97.7)
  US or Canadian medical school graduate: (Yes) 270 (76.5)
Practice Setting Characteristics
  Primary practice location:
    Office (non-hospital based) 216 (62.3)
    Hospital 118 (34.0)
    Community health center 13 (3.8)
  Practice size:
    1–5 physicians 148 (42.2)
    6–10 physicians 65 (18.5)
    11–20 physicians 53 (15.1)
    21–100 physicians 47 (13.4)
    >100 physicians 38 (10.8)
  PCPs are part of practice group: (Yes) 116 (32.5)
  Type of medical record used:
    Paper 37 (10.4)
    Partial EHR or in transition from paper to full EHR 70 (19.8)
    Full EHR 247 (69.8)
  CanCORS Site:
    5 HMOs 22 (6.2)
    8 counties in northern California 79 (22.1)
    State of Alabama 27 (7.6)
    Los Angeles county 93 (26.1)
    State of Iowa 41 (11.5)
    23 counties in North Carolina 42 (11.8)
    Veterans Affairs medical centers 53 (14.9)
Physician Beliefs and Practice Style
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N (%)
  Teaches medical students and/or residents: (Yes) 168 (47.2)
  Number of newly-diagnosed colorectal or lung cancer patients seen per
  month:
    <5 111 (31.1)
    5–9 103 (28.9)
    10–19 85 (23.8)
    ≥20 54 (15.1)
  Believes that early-stage colon cancer survivors should continue regular
  follow-up visits to the oncologist indefinitely
58 (16.3)
  Believes that early-stage lung cancer survivors should continue regular
  follow-up visits to the oncologist indefinitely
81 (22.7)
Physician Communication
  Number of patients completing adjuvant chemotherapy for whom the
  oncologist communicated with patients’ PCPs about status and post-
  treatment recommendations
    All 177 (49.6)
    Most 90 (25.1)
    Some 46 (12.9)
    None 44 (12.4)
  Mode of communication
    More often uses new technologies (integrated EHR, e-mail) 75 (21.0)
    More often uses traditional mode (written correspondence, telephone) 167 (46.7)
    No dominant pattern 53 (15.0)
    Does not routinely communicate with PCP using these modes 62 (17.3)
  Intensity of communication with written correspondence, telephone,
  integrated EHR, or e-mail
    Always/usually uses >1 mode 86 (24.2)
    Always/usually uses 1 mode 209 (58.5)
    Always/usually uses 0 modes 62 (17.3)
PCP: primary care physician; EHR: electronic health record; US: United States; HMO: health maintenance organization; CanCORS: Cancer Care 
Outcomes Research and Surveillance Consortium
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Table 2
Oncologists’ reported involvement in managing their patients’ post-treatment general medical care and cancer-
related cancer needs
I lead
% (95% CI)
I co-manage
% (95% CI)
PCP/other
physician leads
% (95% CI)
Other
% (95% CI)
General medical care
  Routine screening for
  cancers other than colon
  or lung 21.5 (17.4, 26.2) 30.6 (25.9, 35.7) 45.5 (39.9, 51.3) 2.4 (0.7, 7.9)
  Newly-diagnosed
  hypertension 2.9 (1.4, 6.0) 12.3 (8.9, 16.6) 83.0 (78.3, 86.8) 1.8 (0.4, 8.5)
  New weight gain 7.8 (5.1, 11.7) 26.8 (22.4, 31.7) 62.6 (57.0, 67.9) 2.7 (1.0, 7.5)
  Development of
  depression 13.3 (9.6, 18.2) 50.7 (44.9, 56.4) 34.8 (29.8, 40.3) 1.2 (0.1, 12.0)
  Smoking 23.0 (18.6, 28.0) 57.7 (52.2, 63.0) 18.2 (14.4, 22.8) 1.1 (0.1, 13.8)
  New sexual dysfunction 5.6 (3.6, 8.6) 41.6 (36.2, 47.2) 50.9 (45.6, 56.3) 1.9 (0.8, 4.7)
Cancer-related care
  Surveillance for colon or
  lung cancer 81.8 (76.4, 86.2) 12.8 (9.1, 17.9) 4.3 (2.5, 7.3) 1.1 (0.1, 20.1)
  Anemia (colon) 79.5 (74.5, 83.7) 17.5 (13.7, 22.0) 2.6 (1.1, 5.7) 0.5 (0.1, 3.7)
  Diarrhea (colon) 57.1 (51.6, 62.5) 30.8 (26.0, 36.0) 11.5 (8.3, 15.6) 0.7 (0.2, 2.6)
  Persistent cough (lung) 67.4 (62.1, 72.3) 28.0 (23.3, 33.2) 4.6 (2.7, 7.6) 0
  Shortness of breath (lung) 64.1 (58.7, 69.2) 31.7 (26.8, 37.0) 4.2 (2.4, 7.1) 0
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Table 3
Factors associated with oncologists who report co-managing a greater number of post-treatment general 
medical care roles with PCPs
OR (95% CI)
Physician characteristics
  Gender: (Male) 1.17 (0.74, 1.86)
    Female 1.00
  Years since graduation from medical school:
    <20 0.57 (0.32, 1.01)
    20–29 1.00
    ≥30 0.89 (0.56, 1.42)
  Race/ethnicity:
    Non-Hispanic White 0.81 (0.44, 1.51)
    Non-Hispanic Asian 0.82 (0.39, 1.75)
    Other 1.00
  Board certified: (Yes) 2.53 (0.52, 12.40)
    No 1.00
  US or Canadian medical school graduate: (Yes) 0.65 (0.38, 1.12)
    No 1.00
Practice setting characteristics
  Primary practice location:
    Office (non-hospital based) 1.00
    Hospital 0.72 (0.42, 1.22)
    Community health center 1.50 (0.60, 3.77)
  Practice size:
    1–5 physicians 1.00
    6–10 physicians 0.83 (0.45, 1.52)
    11–20 physicians 1.02 (0.52, 2.03)
    21–100 physicians 0.69 (0.33, 1.45)
    >100 physicians 0.89 (0.42, 1.88)
  PCPs are part of practice group: (Yes) 0.84 (0.49, 1.44)
    No 1.00
  Type of medical record used:
    Paper 1.00
    Partial EHR or in transition from paper to full EHR 0.87 (0.37, 2.09)
    Full EHR 1.42 (0.66, 3.07)
  CanCORS Site:
    5 HMOs 2.63 (0.90, 7.68)
    8 counties in northern California 2.63 (1.24, 5.59)
    State of Alabama 1.49 (0.57, 3.92)
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OR (95% CI)
    Los Angeles county 2.11 (1.00, 4.47)
    State of Iowa 1.00
    23 counties in North Carolina 3.72 (1.58, 8.75)
    Veterans Affairs medical centers 3.21 (1.41, 7.29)
Physician Beliefs and Practice Style
  Teaches medical students and/or residents: (Yes) 1.16 (0.71, 1.91)
    No 1.00
  Number of newly-diagnosed colorectal or lung cancer patients seen
  per month:
    <5 1.00
    5–9 1.24 (0.72, 2.12)
    10–19 1.01 (0.55, 1.86)
    ≥20 0.90 (0.50, 1.64)
  Believes that early-stage colon cancer survivors should
  continue regular follow-up visits to the oncologist indefinitely: (No)
1.33 (0.62, 2.84)
    Yes 1.00
  Believes that early-stage lung cancer survivors should continue
  regular follow-up visits to the oncologist indefinitely: (No)
0.60 (0.31, 1.15)
    Yes 1.00
  Mode of communicating clinical information with PCPs,
  post-treatment
    Prefers new technologies (integrated EHR, email) 0.93 (0.47, 1.83)
    Prefers traditional mode (written correspondence, telephone) 1.44 (0.71, 2.91)
    No dominant pattern 1.60 (0.75, 3.41)
    Does not routinely communicate with PCP 1.00
PCP: primary care physician; EHR: electronic health record; US: United States; HMO: health maintenance organization; CanCORS: Cancer Care 
Outcomes Research and Surveillance Consortium
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